Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis

Human Reproduction

Volumn 21, Issue 12, 2006, Pages 3059-3067

  Collette, T ^a   Maheux, R ^a,b   Mailloux, J ^b   Akoum, Ali ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Endometriosis; Endometrium; Matrix metalloproteinase 9; Tissue inhibitor of matrix metalloproteinase

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; GELATINASE B; GELATINASE INHIBITOR; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; ECTOPIC TISSUE; ENDOMETRIOSIS; ENDOMETRIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOREACTIVITY; LEUKOCYTE; MACROPHAGE; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROMA; T LYMPHOCYTE; ZYMOGRAPHY;

EID: 33751357897     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del297     Document Type: Article

References (50)

1. 7) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67,817-821.
2. Bellehumeur C, Collette T, Maheux R, Mailloux J, Villeneuve M and Akoum A (2005) Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis. Hum Reprod 20,1177-1184.
3. Bergqvist A, Ferno M and Mattson S (1996) A comparison of cathepsin D levels in endometriotic tissue and in uterine endometrium. Fertil Steril 65,1130-1134.
4. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J and Osteen KG (2002) Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 87,4782-4791.
5. Bruse C, Bergqvist A, Carlstrom K, Fianu-Jonasson A, Lecander I and Astedt B (1998) Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women. Fertil Steril 70,821-826.
6. Chen QH, Qu JY, Xu YY, Qiu NX, Zhuang YZ, Zhong S and Fang QQ (2004) [Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium]. Zhonghua Fu Chan Ke Za Zhi 39,809-812.
7. Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y and Polan ML (2002) Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 78,787-795.
8. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH and Lake Polan M (2001) Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: A rationale for endometriotic invasiveness. Fertil Steril 75,152-159.
9. Collette T, Bellehumeur C, Kats R, Maheux R, Mailloux J, Villeneuve M and Akoum A (2004) Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 19,1257-1264.
10. Cornet PB, Galant C, Eeckhout Y, Courtoy PJ, Marbaix E and Henriet P (2005) Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. J Clin Endocrinol Metab 90,1001-1011.
11. Cox KE, Piva M and Sharpe-Timms KL (2001) Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol Reprod 65,1297-1303.
12. Duncan WC, McNeilly AS and Illingworth PJ (1998) The effect of luteal 'rescue' on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum. J Clin Endocrinol Metab 83,2470-2478.
13. Freitas S, Meduri G, Le Nestour E, Bausero P and Perrot-Applanat M (1999) Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod 61,1070-1082.
14. Giudice LC, Tazuke SI and Swiersz L (1998) Status of current research on endometriosis. J Reprod Med 43,252-262.
15. Goldberg GI, Strongin A, Collier IE, Genrich LT and Marmer BL (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267,4583-4591.
16. Guan YM, Carlberg M, Bruse C, Carlstrom K and Bergqvist A (2002) Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells. Acta Obstet Gynecol Scand 81,389-397.
17. Halme J, Hammond MG, Hulka JF, Raj SG and Talbert LM (1984) Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 64,151-154.
18. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ and van Hinsbergh VW (1993) Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 296(Pt 3),803-809.
19. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R and Uehira M (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17,177-181.
20. Jeziorska M, Nagase H, Salamonsen LA and Woolley DE (1996) Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J Reprod Fertil 107,43-51.
21. Kats R, Metz CN and Akoum A (2002) Macrophage migration inhibitory factor is markedly expressed in active and early-stage endometriotic lesions. J Clin Endocrinol Metab 87,883-889.
22. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G and Denhardt DT (1989) Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243,947-950.
23. Kokorine I, Nisolle M, Donnez J, Eeckhout Y, Courtoy PJ and Marbaix E (1997) Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil Steril 68,246-251.
24. Koks CA, Groothuis PG, Slaats P, Dunselman GA, de Goeij AF and Evers JL (2000) Matrix metalloproteinases and their tissue inhibitors in antegradely shed menstruum and peritoneal fluid. Fertil Steril 73,604-612.
25. Lebovic DI, Mueller MD and Taylor RN (2001) Immunobiology of endometriosis. Fertil Steril 75,1-10.
26. Li L, Chen S and Xing F (2000) [Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 protein in the implantation window phase of endometrium]. Zhonghua Fu Chan Ke Za Zhi 35,544-546.
27. Liu XJ, He YL and Peng DX (2002) Expression of metalloproteinase-9 in ectopic endometrium in women with endometriosis. Di Yi Jun Yi Da Xue Xue Bao 22,467-469.
28. Mantovani A, Bonecchi R, Martinez FO, Galliera E, Perrier P, Allavena P and Locati M (2003) Tuning of innate immunity and polarized responses by decoy receptors. Int Arch Allergy Immunol 132,109-115.
29. Mantovani A, Locati M, Vecchi A, Sozzani S and Allavena P (2001) Decoy receptors: A strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 22,328-336.
30. Marbaix E, Kokorine I, Moulin P, Donnez J, Eeckhout Y and Courtoy PJ (1996) Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci USA 93,9120-9125.
31. Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E, Klagsbrun M and Langer R (1996) Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem 60,379-386.
32. Nayak NR, Critchley HO, Slayden OD, Menrad A, Chwalisz K, Baird DT and Brenner RM (2000) Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: Potential relevance to menstruation. J Clin Endocrinol Metab 85,3442-3452.
33. Noyes RW, Hertig AT and Rock J (1975) Dating the endometrial biopsy. Am J Obstet Gynecol 122,262-263.
34. Ota H, Igarashi S, Hayakawa M, Matsui T, Tanaka H and Tanaka T (1996) Effect of danazol on the immunocompetent cells in the eutopic endometrium in patients with endometriosis: A multicenter cooperative study. Fertil Steril 65,545-551.
35. Pepper MS, Montesano R, Mandriota SJ, Orci L and Vassalli JD (1996) Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49,138-162.
36. Ponton A, Coulombe B and Skup D (1991) Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res 51,2138-2143.
37. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC and Gorstein F (1993) Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 168,253-260.
38. Rudolph-Owen LA, Slayden OD, Matrisian LM and Brenner RM (1998) Matrix metalloproteinase expression in Macaca mulatta endometrium: Evidence for zone-specific regulatory tissue gradients. Biol Reprod 59,1349-1359.
39. Sampson J (1927) Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14,422-469.
40. Sharpe-Timms KL (2001) Endometrial anomalies in women with endometriosis. Ann N Y Acad Sci 943,131-147.
41. Sharpe-Timms KL, Keisler LW, McIntush EW and Keisler DH (1998) Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil Steril 69,1128-1134.
42. Shi W, Mognetti B, Campana A and Bischof P (1995) Metalloproteinase secretion by endometrial leukocyte subsets. Am J Reprod Immunol 34,299-310.
43. Sillem M, Prifti S, Monga B, Buvari P, Shamia U and Runnebaum B (1997) Soluble urokinase-type plasminogen activator receptor is over-expressed in uterine endometrium from women with endometriosis. Mol Hum Reprod 3,1101-1105.
44. Skinner JL, Riley SC, Gebbie AE, Glasier AF and Critchley HO (1999) Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod 14,793-799.
45. Strathy JH, Molgaard CA, Coulam CB and Melton LJ III (1982) Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril 38,667-672.
46. Suzumori N, Ozaki Y, Ogasawara M and Suzumori K (2001) Increased concentrations of cathepsin D in peritoneal fluid from women with endometriosis. Mol Hum Reprod 7,459-462.
47. Van Wart HE and Birkedal-Hansen H (1990) The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87,5578-5582.
48. Watari M, Watari H, DiSanto ME, Chacko S, Shi GP and Strauss JF III (1999) Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol 154,1755-1762.
49. Wenzl RJ and Heinzl H (1998) Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants. Gynecol Obstet Invest 45,253-257.
50. Witz CA, Montoya IA, Dey TD and Schenken RS (1994) Characterization of lymphocyte subpopulations and T cell activation in endometriosis. Am J Reprod Immunol 32,173-179.